Frequency of Deletions of EPCAM (TACSTD1) in MSH2-Associated Lynch Syndrome Cases
- 31 January 2011
- journal article
- Published by Elsevier BV in The Journal of Molecular Diagnostics
- Vol. 13 (1), 93-99
- https://doi.org/10.1016/j.jmoldx.2010.11.011
Abstract
No abstract availableFunding Information
- National Cancer Institute, National Institutes of Health (RFA #CA-95-011)
This publication has 47 references indexed in Scilit:
- Risks of Lynch Syndrome Cancers for MSH6 Mutation CarriersJNCI Journal of the National Cancer Institute, 2010
- Germline hypermethylation of MLH1 and EPCAM deletions are a frequent cause of Lynch syndromeGenes, Chromosomes and Cancer, 2009
- Deletions removing the last exon ofTACSTD1constitute a distinct class of mutations predisposing to Lynch syndromeHuman Mutation, 2009
- Molecular Characterization of MSI-H Colorectal Cancer by MLHI Promoter Methylation, Immunohistochemistry, and Mismatch Repair Germline Mutation ScreeningCancer Epidemiology, Biomarkers & Prevention, 2008
- MLH1 germline epimutations in selected patients with early‐onset non‐polyposis colorectal cancerClinical Genetics, 2007
- Characterization of hMLH1 and hMSH2 Gene Dosage Alterations in Lynch Syndrome PatientsGastroenterology, 2005
- Isolated Loss of PMS2 Expression in Colorectal Cancers: Frequency, Patient Age, and Familial AggregationClinical Cancer Research, 2005
- Screening for the Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer)The New England Journal of Medicine, 2005
- Mutation in the DNA mismatch repair gene homologue hMLH 1 is associated with hereditary non-polyposis colon cancerNature, 1994
- Clues to the Pathogenesis of Familial Colorectal CancerScience, 1993